Related Experiment Videos
[C-reactive protein as an important prognostic marker for ischemic stroke]
1Department of Neurology, The Second Affiliated Hospital, Jinan University, Shenzhen 518020, China.
Summary
Elevated C-reactive protein (CRP) levels in ischemic stroke patients correlate with larger cerebral infarctions, carotid plaques, and poorer prognoses. This finding highlights CRP as a key indicator for stroke outcomes.
Area of Science:
- Neurology
- Inflammation research
- Biomarker discovery
Context:
- Inflammatory processes are increasingly recognized for their significant role in the pathophysiology of stroke and the development of carotid plaques.
- Understanding these inflammatory markers can provide insights into stroke progression and patient outcomes.
Purpose:
- To investigate the relationship between serum C-reactive protein (CRP) levels and key indicators of ischemic stroke severity.
- Specifically, to correlate CRP levels with the size of cerebral infarction, the presence and characteristics of carotid plaques, and the overall prognosis of ischemic stroke patients.
Summary:
- A study of 121 ischemic stroke patients found significantly higher leukocyte counts and blood glucose levels in those with abnormal CRP levels.
- Abnormal CRP levels were associated with a higher incidence of territorial infarction, increased occurrence of carotid plaques, and more severe neurological deficits (higher CNFD scores).
- Patients with elevated CRP also exhibited a significantly more severe prognosis.
Impact:
- Serum CRP levels serve as a crucial prognostic marker in the context of ischemic stroke.
- This research underscores the utility of CRP as a readily measurable biomarker for assessing stroke severity and predicting patient outcomes.
- Findings support the integration of CRP monitoring into clinical practice for better stroke management and risk stratification.